Taiwan FDA registration dc5b23077a23e3d422fee33563a56aea
“Mölnlycke” Granulox Woundspray
TW: “墨尼克”氧療舒傷口噴劑
Taiwan·Risk Class 3·MD·Hälsa Pharma GmbH·Registered Jun 13, 2018 – Jun 13, 2028ActiveRegistration details
- Analysis ID
- dc5b23077a23e3d422fee33563a56aea
- License Form
- Ministry of Health Medical Device Import No. 030980
- Customs Code
- DHA05603098005
Company information
- Manufacturer
- Hälsa Pharma GmbH
- Manufacturer Country
- Germany
- Authorized Representative
- MOLNLYCKE HEALTH CARE TAIWAN CO., LTD.
Product details
- Intended Use
- This product is suitable for the treatment of chronic wounds, such as venous ulcers on the legs, arterial ulcers, mixed ulcers, diabetic foot ulcers, secondary healing surgical wounds, and pressure injuries (pressure ulcers), and can also be used for wounds of debridement of carrion and infectious tissues.
- Product Type (Level 1)
- I General and plastic surgical devices
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jun 13, 2018
- Expiry Date
- Jun 13, 2028
About this record
Access comprehensive regulatory information for “Mölnlycke” Granulox Woundspray in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number dc5b23077a23e3d422fee33563a56aea and manufactured by Hälsa Pharma GmbH. The authorized representative in Taiwan is MOLNLYCKE HEALTH CARE TAIWAN CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices